Sensitive ASX Announcement

FDA Approval to Commence Alzheimer's Disease Clinical Trial

Published: 03/01/17, 09:29am (AEST)2 pages
Actinogen Medical Limited
ACW:ASXHealthcare

Recent ACW Announcements

Price Sensitive only